COURSE DIRECTOR: P. Courvalin (Institut Pasteur)
SCIENTIFIC ADVISORS: M. Gilmore (Harvard Medical School), G. Wright (McMaster University)
SCIENTIFIC COMMITTEE: G. Challis, T. Dougherty, C. Grillot-Courvalin, D. Hughes, S. Lahiri, F. Lebreton, S. Lory, A. Myers, S. Projan, H.-G. Sahl, M.-W. Tan
OBJECTIVE: The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for the study of resistance and antibiotic discovery will be examined.
COURSE: The faculty, composed of 40 internationally recognized scientists and physicians who have made important contributions to antibiotic development, infectious diseases, and resistance management will be in residence for a minimum of two days for informal interactions. Graduates will emerge with a state-of-the-art understanding of existing antibiotics: modes of action, mechanisms of resistance, approaches for mining chemical space, advancing hits to leads, the application of next-generation nucleic acid-based technologies for antibiotic discovery, and resistance detection. The course aims to build an international cadre of collaborative, well networked, and highly-trained specialists.
AUDIENCE: ICARe is designed for assistant professors, post-doctoral and ID fellows, new scientists from diagnostic, pharmaceutical industry, or from biotech, either working in or contemplating entering the field of antibiotics. Decision-makers involved in the discovery, development, and approval of new antibiotics, in the elaboration of programs for better use of antibiotics and reducing the development of resistance. From both the public and private sectors. Attendance will be limited to 40 students.
SELECTION CRITERIA: Participants will be selected by the Scientific Committee that will ensure that the participants reflect the global nature of the problem with special attention to gender equality, educational background, involvement in the field of antibiotics (research projects, scientific or industrial, which could be presented during the course are welcome), and decision-making responsibility in the finding of new antibiotics and of their appropriate use.
FORMAT: The course will be administered over 9 days and will consist of formal instruction and hands-on bioinformatics.
Application Deadline: TBD.